Motivational Approach to Treat Childhood Obesity
OBEMAT20
Clinical and Metabolic Efficacy of the Motivational Approach, Coordinated Between Primary Care and the Clinical Health Services for Childhood Obesity Treatment: Randomized Clinical Trial
1 other identifier
interventional
319
1 country
4
Brief Summary
The treatment of childhood obesity is challenging. Although dietary and physical activity recommendations are widely known, the willingness to change lifestyles within the family is not easy to be achieved. Motivational interviewing has been shown as a possibly effective method to increase adherence to dietary recommendations in the obese adult. There is scarce evidence showing whether implementing a motivational interview in obese children could be effective. The aim of this clinical trial is assessing the effect of a motivational interview, coordinated between the clinical and primary care services on 8 to 14 years old obese children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 8, 2018
CompletedFirst Posted
Study publicly available on registry
November 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJune 3, 2024
May 1, 2024
5 years
October 8, 2018
May 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body Mass Index z-score
Changes in BMI z-score between the baseline visit and the final assessment
12 (+3) months
Secondary Outcomes (9)
Abdominal obesity (waist circumference)
12 (+3) months
Abdominal obesity (waist to height)
12 (+3) months
Body composition: fat mass (kg)
12 (+3) months
Body composition: lean mass (kg)
12 (+3) months
Body composition: fat mass index (kg/m2)
12 (+3) months
- +4 more secondary outcomes
Study Arms (2)
Obemat2.0 Intervention Group
EXPERIMENTALIntervention: Obemat2.0 therapy (11 Motivational Interview Visits, 3 Workshops) Duration: 12 months (+3 months). Setting: Primary care centers Providers: pediatritians and nurses trained to perform motivational interview Visits description: The interviews follow a structure: 1. Checking the accomplishment of objectives to congratulate and motivate the patient. 2. A specific topic per visit is explained to the participant and family. 3. A task related to the topic (i.e. to plan a weekly menu for the family) is given to be brought back at the next visit. 4th. Objectives about diet, weight and physical activity are defined to be accomplished until the next visit. The follow-up of the structure is ensured by means of a printed material that the therapists provide each visit to participants.
Control Group
ACTIVE COMPARATORControl Intervention: regular practise in primary care (11 individual monthly visits) Duration: 12 months (+3 months). Setting: Primary care centers. Providers: standard pediatritians and nurses Children and their families receive the usual recommendations conducted in primary care centers based on the Clinical Practice Guidelines on the Prevention and Treatment of Child and Adolescent Obesity. At visits, the family receive explanations about carrying out a balanced diet, divided into 5 meals, to provide a moderate energy reduction from the previous intake. An increase in physical activity, both in terms of leisure activity, as sports regular practise is recommended. Monthly visits are organized in which weight and height are measured and compliance with advice is reviewed.
Interventions
Eligibility Criteria
You may qualify if:
- Age range between 8 and \<14 years at enrolment (so that, children would end the treatment at maximum age of 15 years
- BMI \> 97th percentile of Hernandez references from 1988 (Hernández et al., 1988) as indicated by the Guidelines for Clinical Practice of the Spanish Health System (Grupo de trabajo de la Guía de Práctica Clínica sobre la Prevención y el Tratamiento de la Obesidad Infantojuvenil. Ministerio de Ciencia e Innovación \[Spanish Ministry of Sciencee and Innovation\], 2009) for the diagnose of the childhood obesity.
You may not qualify if:
- Children with eating disorders
- Families not available to attend to scheduled visits
- Simultaneous participation in another clinical trial
- Presence of endocrine disorders (GH disorder, hypothyroidism, Cushing's disease, early puberty or other)
- Lack of command of local languages
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Investigacio Sanitaria Pere Virgililead
- Institut Català de la Salutcollaborator
- Hospital Universitari Joan XXIII de Tarragona.collaborator
- Hospital Universitari Sant Joan de Reuscollaborator
- Instituto de Salud Carlos IIIcollaborator
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurinacollaborator
- University Rovira i Virgilicollaborator
Study Sites (4)
Faculty of Medicine, C/ Sant Llorenç 21
Reus, Tarragona, 43201, Spain
Iispv- Hospital Sant Joan de Reus
Reus, Tarragona, E43204, Spain
IDIAP Jordi Gol
Reus, Tarragona, Spain
Hospital de Tarragona Joan XXIII
Tarragona, 43005, Spain
Related Publications (2)
Luque V, Feliu A, Escribano J, Ferre N, Flores G, Monne R, Gutierrez-Marin D, Guillen N, Munoz-Hernando J, Zaragoza-Jordana M, Gispert-Llaurado M, Rubio-Torrents C, Nunez-Roig M, Alcazar M, Ferre R, Basora JM, Hsu P, Alegret-Basora C, Arasa F, Venables M, Singh P, Closa-Monasterolo R. The Obemat2.0 Study: A Clinical Trial of a Motivational Intervention for Childhood Obesity Treatment. Nutrients. 2019 Feb 16;11(2):419. doi: 10.3390/nu11020419.
PMID: 30781525BACKGROUNDLuque V, Feliu A, Closa-Monasterolo R, Munoz-Hernando J, Ferre N, Gutierrez-Marin D, Guillen N, Basora J, Hsu P, Alegret-Basora C, Serrano MA, Mallafre M, Alejos AM, Balcells EN, Boada A, Paixa S, Mimbrero G, Gil-Mancha S, Tudela-Valls C, Alcazar M, Escribano J; Obemat2.0 Study Group. Impact of the motivational interviewing for childhood obesity treatment: The Obemat2.0 randomized clinical trial. Pediatr Obes. 2024 Jul;19(7):e13125. doi: 10.1111/ijpo.13125. Epub 2024 May 11.
PMID: 38733242RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Given the nature of the intervention participants or researchers could not be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. PhD
Study Record Dates
First Submitted
October 8, 2018
First Posted
November 21, 2018
Study Start
January 1, 2016
Primary Completion
December 30, 2020
Study Completion
December 31, 2021
Last Updated
June 3, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share